
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Cyntegrity, Germany’s provider of intelligent risk-based quality management (RBQM) solutions to the Life Sciences industry, has announced the launch of MyRBQM Portal - a full-service business intelligence and analytics cloud specifically designed for clinical trial purposes.
MyRBQM Portal responds to the practical implementation needs of CROs, Biopharma and MedTech enterprises transiting to risk-oriented processes mandated by today’s GCP guideline ICH E6 (R2) and EU MDR.
For more information, visit www.cyntegrity.com






